Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Renal and Vascular Endstage Disease Intervention Trial

NCT03073018 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03073018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03073018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Renal and Vascular Endstage Disease Intervention Trial
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Completed
Start date
April 30, 1998
Completion date
November 30, 2003
Enrollment
864 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, microalbuminuria, renal disease